News

In the latest close session, Caterpillar (CAT) was down 2.08% at $428.91. This change lagged the S&P 500's 1.6% loss on the day. Elsewhere, the Dow saw a downswing of 1.23%, while the tech-heavy

CleanSpark (CLSK) closed the most recent trading day at $10.44, moving -8.22% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 1.6%. At the same

Friday, August 1, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp.

Flora Growth Corp. (FLGC) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.22 per share a year ago. These

Investors in Archrock, Inc. AROC need to pay close attention to the stock based on moves in the options market lately. That is because the August 15, 2025 $12.5 Call had some of the highest implied

Investors in Five Below, Inc. FIVE need to pay close attention to the stock based on moves in the options market lately. That is because the August 15, 2025 $35 Put had some of the highest implied

The broader indexes have cooled off in the last few trading sessions after what was another pleasant month for the stock market in July.

While the market has been able to shrug off trade war

TELUS Digital (TIXT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.16 per share a year ago. These

Balchem (BCPC) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.98 per share a year ago. These figures

Tempus AI, Inc. TEM is scheduled to report second-quarter 2025 results on Aug. 8.

In the last reported quarter, the company’s adjusted loss of 24 cents was narrower than the Zacks Consensus Estimate

Dominion Energy (D) reported $3.81 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 9.3%. EPS of $0.75 for the same period compares to $0.55 a year ago.

Navitas Semiconductor NVTS is set to release its second-quarter 2025 results on Aug. 4.For the second quarter of 2025, net revenues are expected to be between $18 and $20 million. The Zacks

Shares of CNO Financial Group, Inc. CNO have lost 2% since it reported second-quarter 2025 results on July 28. The quarterly results were hurt by a rise in total expenses as a result of higher

Oddity Tech ODD is scheduled to release second-quarter 2025 results on Aug. 4.For the to-be-reported quarter, ODD expects non-GAAP earnings between 85 cents and 89 cents per share. Revenues are

For the quarter ended June 2025, Stryker (SYK) reported revenue of $6.02 billion, up 11.1% over the same period last year. EPS came in at $3.13, compared to $2.81 in the year-ago quarter.

The

ICF International (ICFI) reported $476.16 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 7%. EPS of $1.66 for the same period compares to $1.69 a year

Shares of National Research Corporation NRC have declined 10% since the company reported its earnings for the quarter ended June 30, 2025. This compares to the S&P 500 index’s 0.7% decline over the

Franklin Resources Inc. BEN reported third-quarter fiscal 2025 (ended June 30) adjusted earnings of 49 cents per share, which surpassed the Zacks Consensus Estimate of 48 cents per share. However

Stocks have made impressive gains over the last few months and are currently at or near all-time record levels.Many in the market are hoping that the worst is behind us and that the rebound from the

KLA Corporation KLAC reported fourth-quarter fiscal 2025 non-GAAP earnings of $9.38 per share, beating the Zacks Consensus Estimate by 10%. The figure surged 42.1% year over year.Revenues increased

Kimberly-Clark Corporation KMB posted second-quarter 2025 results, wherein the top and bottom lines beat the Zacks Consensus Estimate, while both decreased from the year-ago period’s actuals

Moderna MRNA incurred a loss of $2.13 per share in the second quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of $2.99. In the year-ago period, the company had reported a loss

News Corporation NWSA is scheduled to report fourth-quarter fiscal 2025 results on Aug. 5.The Zacks Consensus Estimate for revenues is pegged at $2.10 billion, indicating a decline of 18.37% from